Testosterone Treatment Lawsuits More Than Doubled Last Month As The FDA Continues To Investigate Risks

The Number of Testosterone Treatment Lawsuits Filed Alleging Heart Attacks, Strokes, And Other Cardiac Events Were Due To Testosterone Therapy Drugs Such as AndroGel and Androderm Has Grown to 98, Reports Wright & Schulte LLC

Testosterone treatment lawsuits continue to mount as Wright & Schulte LLC notes that as of June 16th, there are complaints filed against the makes of testosterone treatment products such as Androgel, Androderm, Testim and Depot are pending under MDL 2545 in the U.S. District Court of Illinois, and all allege that taking one or more testosterone replacement drugs caused them to experience strokes, heart attacks, blood clots, and other health problems. The attorneys are looking at the rate the number is growing since there were almost half the amount of testosterone treatment lawsuits pending when a panel of federal judges issued an order on June 6th to transfer the low testosterone claims to the U.S. District Court, Northern District of Illinois. That is almost double in under a month. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)
[jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf]
[jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-16-2014.pdf]

The firm is actively investigating the side-effects of testosterone treatment drugs and continues to offer free legal evaluations to men or families of men who believe they have suffered cardiac events due to testosterone therapy drugs such as AndroGel, Androderm, and Testim. To speak with an experienced attorney regarding your legal option contact Wright & Schulte LLC by calling 1-800-399-0795 or visit yourlegalhelp.com. You can also follow us on Facebook and Like us on Twitter for all the news on testosterone treatment products and other harmful drugs.

According to court records, testosterone treatment lawsuit filings began in January after the U.S. Food & Drug Administration (FDA) announced it was launching an investigation into the safety of prescription testosterone products taken by men who suffer from hypogonadism (low testosterone). The FDA’s re-evaluation of low testosterone medication was triggered by a review of two observational studies. The first study, published in the PLOS One Journal on January 29, 2014, found that men over 65 and younger men with a pre-existing heart disease who used prescribed testosterone drugs were at a greater risk of having a heart attack within the first 90 days after taking the medication for the first time. The second study, published in the November 2013 Journal of the American Medical Association, found that older men who had underlying cardiovascular disease and took low testosterone treatment had a 30 percent increased risk of having a stroke, heart attack or death compared to men who did not take the medication.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]
[plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805, January 29, 2014]
[jama.jamanetwork.com/article.aspx?articleid=1764051, November 6, 2013]

Two weeks after the judicial panel consolidated all testosterone lawsuits pending across the country, the FDA ordered testosterone manufacturers to include a general warning about the risk of venous blood clots on their drug labels. The federal regulator acknowledged that drug labels already include the risk of blood clots in veins as a consequence of polycythemia, an abnormal increase in the number of red blood cells that sometimes occurs with testosterone treatment. According to the FDA, post-market reports have shown that blood clots are occurring that are unrelated to polycythemia. Because of this development, the federal agency said in its June 19th safety alert that it wants the labeling on all FDA-approved testosterone products to be consistent in including a general warning about the risk of venous blood clots.
[fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm402054.htm, June 20, 2014]
[fda.gov/Drugs/DrugSafety/ucm401746.htm, June 19, 2014]

In the wake of the FDA’s announcement on the possible cardiac risks associated with low testosterone treatment drugs, doctors are complaining that research on the safety of testosterone replacement therapy is inconclusive and leaves them wondering how and whether to treat hypogonadism, according to a Los Angeles Times report. An endocrinologist quoted in the article suggests that researchers launch large, randomized clinical trials in which some men are given low testosterone medication and others are given a placebo and follow both groups for several years. The problem with existing research, according to the endocrinologist, is that it infers but does not prove that there are risks associated with testosterone medication.
[latimes.com/science/sciencenow/la-sci-sn-testosterone-supplement-debate-20140428-story.html, April 28, 2014]

Wright & Schulte LLC offers free legal consultations to men who experienced heart attack, stroke, blood clots and other side effects believed to be associated with the use of testosterone replacement therapy drugs such as AndroGel, Androderm, Testim and Depo Testosterone. To find out whether you are eligible to file your own low testosterone lawsuit, please contact the attorneys at Wright & Schulte LLC by calling 1800-399-0795 or visit yourlegalhelp.com.

About Wright & Schulte LLC

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free low testosterone lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

To have a FREE Case Review conducted please call the number above or complete the form below. We will review your case promptly and contact you to discuss confidentially the process of seeking compensation.

First Name:

Last Name:

Email:

Phone:

Provide Details About Your Case:
By submitting this form, you give Wright & Schulte LLC permission to contact you confidentially.

Disclaimer: Requesting a legal consultation or claim review does not form an attorney client relationship and you are not considered a client until a retainer agreement has been signed and your case has been accepted. The contents of this site are provided for informational purposes only and do not constitute legal or medical advice. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Please discuss any health or other concerns with your doctor or other healthcare professional. No recommendation or endorsement of Wright Schulte LLC is implied by reference to any newspaper or television or radio station.
Your use of this web site, or sending of email to Wright Schulte LLC, does not create an attorney- client relationship between you and Wright Schulte LLC.

Privacy Policy: Wright Schulte LLC maintains the strict and confidential privacy of your message. We do not transfer your personal information, including your email address, to any third party. Information entered in the form will be used solely for informational purposes to assist in your case investigation.